Explore professionally built ETF model portfolios. Discover now →

Advertisement
Advertisement

TMEDvsHTECETF Comparison

ETF 1
TMED

T. Rowe Price Health Care ETF

This fund is part of
US Health Care
-0.76%
VS
ETF 2
HTEC

Robo Global Healthcare Technology and Innovation ETF

This fund is part of
Multiple Trends
-1.93%

T. Rowe Price Health Care ETF (TMED) belongs to the US Health Care segment. Robo Global Healthcare Technology and Innovation ETF (HTEC) is part of the Multiple Trends segment. TMED's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Non-Corporate. In contrast, HTEC's top sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. TMED is less expensive with a Total Expense Ratio (TER) of 0.44%, versus 0.8% for HTEC. TMED is up 15.73% year-to-date (YTD) with +$13M in YTD flows. HTEC performs worse with 14.78% YTD performance, and +$11M in YTD flows. Run a side-by-side ETF comparison of TMED and HTEC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

TMED vs HTEC performance and flow charts

Performance

-2.00.02.04.06.0%Aug 10Aug 17Aug 25Sep 1Sep 8

Cumulative Flows

01,000,0002,000,0003,000,0004,000,000Aug 10Aug 17Aug 25Sep 1Sep 8

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/09/2026
1M3MYTD1Y3Y5Y
Perf.
TMED
HTEC
-2.89%-1.31%
+7.47%+17.19%
+15.73%+14.78%
+32.67%+35.23%
n/a+49.78%
n/a-16.19%
Flows
TMED
HTEC
+$4M-$5K
+$10M+$7M
+$13M+$11M
+$15M+$10M
--$29M
--$91M
Volatility and drawdown
3M1Y3Y5Y
Volatility
TMED
HTEC
+18.12%+22.45%
+18.46%+21.16%
n/a+20.94%
n/a+24.24%
Max drawdown
TMED
HTEC
-6.37%-6.70%
-11.09%-16.84%
n/a-22.68%
n/a-55.10%
Max drawdown duration
TMED
HTEC
21d16d
125d160d
n/a237d
n/a1817d
Trading data

Create an account to view trading data

Join for free
TMED
HTEC
Last sale
9/11/2026 at 1:30 PM
$33.80
$40.73
Previous close
09/10/2026
$33.89
$40.42
Consolidated volume
09/10/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

TMED
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
TMED
HTEC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
TMED
HTEC
Last price
$33.80
$40.73
1D performance
-0.25%
+0.78%
AuM$32.63 M$73.24 M
E/R0.44%0.8%
Characteristics
TMED
HTEC
Management strategyActivePassive
ProviderT. Rowe PriceROBO Global ETFs
Benchmark-ROBO Global Healthcare Technology and Innovation
N° of holdings9763
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateJune 11, 2025June 25, 2019
ESGNoYes
Advertisement
Exposure

Countries

TMED
USA
93.59%
Other
6.41%
HTEC
USA
75.7%
Other
24.3%

Sectors

TMED
Healthcare
98.58%
Other
1.42%
HTEC
Healthcare
94.38%
Other
5.62%
Advertisement

Diversification

TMED

Total weight of top 15 holdings out of 15

61.11%
HTEC

Total weight of top 15 holdings out of 15

31.72%

Top 15 holdings

Data as of July 31, 2026
TMED
Eli Lilly & Co.
16.65%
UnitedHealth Group, Inc.
5.89%
Thermo Fisher Scientific, Inc.
4.44%
Alnylam Pharmaceuticals, Inc.
4.11%
Gilead Sciences, Inc.
3.76%
Danaher Corp.
3.58%
Cencora, Inc.
3.30%
Insulet Corp.
2.73%
Agilent Technologies, Inc.
2.69%
DexCom, Inc.
2.66%
Dyne Therapeutics, Inc.
2.60%
Stryker Corp.
2.49%
West Pharmaceutical Services, Inc.
2.29%
Waters Corp.
2.20%
McKesson Corp.
1.72%
HTEC
CareDx, Inc.
2.68%
Guardant Health, Inc.
2.32%
Natera, Inc.
2.23%
Twist Bioscience Corp.
2.23%
Thermo Fisher Scientific, Inc.
2.18%
Medpace Holdings, Inc.
2.12%
Adaptive Biotechnologies Corp.
2.11%
IQVIA Holdings, Inc.
2.10%
Illumina, Inc.
2.09%
Arrowhead Pharmaceuticals, Inc.
2.08%
Regeneron Pharmaceuticals, Inc.
1.97%
Glaukos Corp.
1.92%
Vertex Pharmaceuticals, Inc.
1.91%
Stryker Corp.
1.91%
LivaNova Plc
1.87%
Frequently asked questions about TMED and HTEC

How have the TMED and HTEC ETFs performed in 2026?

As of September 9, 2026, TMED is up 15.73% year-to-date (YTD), while HTEC has returned 14.78%. That puts TMED better performer ahead so far this year.

Which ETF is attracting more investor money: TMED or HTEC?

Year-to-date, the TMED ETF saw +$13M in flows, compared to +$11M for HTEC.

Which ETF is more volatile: TMED or HTEC?

Over the past year, TMED had a volatility of 18.46%, while HTEC experienced 21.16%.

Which ETF is bigger: TMED or HTEC?

As of September 9, 2026, TMED holds $32.63 M in assets under management (AUM), while HTEC manages $73.24 M.

What sectors do the TMED and HTEC ETFs invest in?

TMED leans toward sectors like Healthcare. Meanwhile, HTEC focuses on Healthcare.

What are the top holdings of the TMED ETF and HTEC ETF?

TMED top holdings include Eli Lilly & Co., UnitedHealth Group, Inc. and Thermo Fisher Scientific, Inc.. HTEC holds in its top three: CareDx, Inc., Guardant Health, Inc. and Natera, Inc..

Which ETF is more diversified: TMED or HTEC?

TMED holds 97 securities with 61.11% of its assets in the top 15. HTEC has 63 securities and a top 15 weight of 31.72%.

Advertisement
Latest news about TMED & HTEC
Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up